The Michigan Engineer News Center

Medical supply chains are fragile in the best of times and COVID-19 will test their strength

The pipeline of pharmaceuticals is easily disrupted.| Short Read

By Mark Daskin and Emily Tucker

The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named.

As operations engineers who focus on how these supply chains work, we know that even in the best of times, the U.S. drug supply chain is relatively fragile. Shortages regularly occur, and the COVID-19 pandemic has the potential to further disrupt a system that patients depend on, sometimes for life or death.

This article is republished from The Conversation. Read the full article.

Portrait of Gabe Cherry


Gabe Cherry
Senior Writer & Assistant Magazine Editor

Michigan Engineering
Communications & Marketing

(734) 763-2937

3214 SI-North

  • Mark Daskin

    Mark Daskin

    Clyde W. Johnson Collegiate Professor Industrial & Operations Engineering

The outside of the Ford Robotics building

U-Michigan, Ford open world-class robotics complex

The facility will accelerate the future of advanced and more equitable robotics and mobility | Medium Read